Medication prior authorization in pediatric hematology and oncology-Reference-Cited by-同舟云学术

Medication prior authorization in pediatric hematology and oncology

Published:2016-11-05 Issue:6 Volume:64 Page:e26339
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Dickens David S.¹²,Pollock Brad H.³

Affiliation:

1. Division of Pediatric Hematology Oncology and Bone Marrow Transplantation; Helen DeVos Children's Hospital (a member of Spectrum Health); Grand Rapids Michigan

2. Department of Pediatrics and Human Development; Michigan State University College of Human Medicine; East Lansing Michigan

3. Department of Public Health Sciences; University of California; Davis California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.26339/fullpdf

Reference17 articles.

1. Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: Results of a longitudinal, population-based study;Law;Clin Ther,2010

2. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: Results of a longitudinal, population-based study;Lu;Clin Ther,2011

3. Implementation of a comprehensive medication prior-authorization service;Leinss;Am J Health Syst Pharm.,2015

4. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population;Bergeson;J Manag Care Pharm,2013

5. Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital;Chan;Pediatr Infect Dis J,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prior authorization for FDA-approved PARP inhibitors in ovarian cancer;Gynecologic Oncology Reports;2024-04

2. Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs;JCO Oncology Practice;2024-01

3. Nearly All Peer-to-Peer Reviews for CT and MRI Prior Authorization Denials for Orthopedic Specialists Are Approved;Orthopedics;2023-11

4. The Patient Experience of Prior Authorization for Cancer Care;JAMA Network Open;2023-10-18

5. Burden with No Benefit: Prior Authorization in Congenital Cardiology;Pediatric Cardiology;2023-09-26